Adage Capital Partners’s Alexion Pharmaceuticals ALXN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q3 | – | Sell |
-5,238,014
| Closed | -$962M | – | 1132 |
|
|
2021
Q2 | $962M | Buy |
5,238,014
+995,635
| +23% | +$171M | 1.88% | 4 |
|
|
2021
Q1 | $649M | Buy |
4,242,379
+1,325,400
| +45% | +$205M | 1.32% | 8 |
|
|
2020
Q4 | $456M | Buy |
2,916,979
+2,106,921
| +260% | +$271M | 0.99% | 11 |
|
|
2020
Q3 | $92.7M | Sell |
810,058
-158,000
| -16% | -$17M | 0.23% | 93 |
|
|
2020
Q2 | $109M | Sell |
968,058
-86,452
| -8% | -$9.18M | 0.28% | 79 |
|
|
2020
Q1 | $94.7M | Buy |
1,054,510
+245,400
| +30% | +$24.1M | 0.28% | 85 |
|
|
2019
Q4 | $87.5M | Buy |
809,110
+242,148
| +43% | +$25.9M | 0.21% | 125 |
|
|
2019
Q3 | $55.5M | Sell |
566,962
-52,500
| -8% | -$5.92M | 0.14% | 188 |
|
|
2019
Q2 | $81.1M | Buy |
619,462
+130,900
| +27% | +$16.9M | 0.2% | 129 |
|
|
2019
Q1 | $66M | Buy |
488,562
+349,500
| +251% | +$43.5M | 0.17% | 155 |
|
|
2018
Q4 | $13.5M | Sell |
139,062
-55,130
| -28% | -$6.52M | 0.04% | 433 |
|
|
2018
Q3 | $27M | Buy |
194,192
+173,698
| +848% | +$21.8M | 0.06% | 338 |
|
|
2018
Q2 | $2.54M | Buy |
20,494
+10,596
| +107% | +$1.24M | 0.01% | 686 |
|
|
2018
Q1 | $1.1M | Buy |
+9,898
| New | +$1.18M | ﹤0.01% | 686 |
|
|
2017
Q4 | – | Sell |
-385,698
| Closed | -$54.1M | – | 770 |
|
|
2017
Q3 | $54.1M | Buy |
385,698
+35,817
| +10% | +$4.87M | 0.13% | 211 |
|
|
2017
Q2 | $42.6M | Buy |
349,881
+118,479
| +51% | +$13.8M | 0.1% | 261 |
|
|
2017
Q1 | $28.1M | Sell |
231,402
-33,600
| -13% | -$4.33M | 0.07% | 334 |
|
|
2016
Q4 | $32.4M | Buy |
265,002
+104,593
| +65% | +$12.8M | 0.09% | 283 |
|
|
2016
Q3 | $19.7M | Buy |
160,409
+129,065
| +412% | +$16.6M | 0.05% | 388 |
|
|
2016
Q2 | $3.66M | Sell |
31,344
-37,219
| -54% | -$5.28M | 0.01% | 614 |
|
|
2016
Q1 | $9.54M | Sell |
68,563
-237,000
| -78% | -$34.8M | 0.03% | 530 |
|
|
2015
Q4 | $58.3M | Buy |
305,563
+25,500
| +9% | +$4.45M | 0.15% | 178 |
|
|
2015
Q3 | $43.8M | Sell |
280,063
-14,100
| -5% | -$2.57M | 0.12% | 219 |
|
|
2015
Q2 | $53.2M | Sell |
294,163
-17,000
| -5% | -$2.93M | 0.13% | 213 |
|
|
2015
Q1 | $53.9M | Sell |
311,163
-83,037
| -21% | -$15M | 0.13% | 211 |
|
|
2014
Q4 | $72.9M | Buy |
394,200
+74,700
| +23% | +$13.8M | 0.18% | 154 |
|
|
2014
Q3 | $53M | Sell |
319,500
-44,400
| -12% | -$7.29M | 0.13% | 204 |
|
|
2014
Q2 | $56.9M | Buy |
363,900
+15,200
| +4% | +$2.4M | 0.15% | 189 |
|
|
2014
Q1 | $53M | Sell |
348,700
-160,100
| -31% | -$25.5M | 0.14% | 192 |
|
|
2013
Q4 | $67.6M | Sell |
508,800
-83,700
| -14% | -$10M | 0.18% | 164 |
|
|
2013
Q3 | $68.8M | Sell |
592,500
-200,000
| -25% | -$21.9M | 0.2% | 147 |
|
|
2013
Q2 | $73.1M | Buy |
+792,500
| New | +$76.4M | 0.23% | 128 |
|
Other funds holding ALXN
BCI
NICM
TAIM
RG
CFO
MAM